APA引文

Utsunomiya, A. (2014). Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma. BioMed Central.

Citação norma Chicago

Utsunomiya, Atae. Mogamulizumab, an Anti-CCR4 Monoclonal Antibody, Is a Potent Therapeutic Option for Adult T-cell Leukemia-lymphoma. BioMed Central, 2014.

MLA引文

Utsunomiya, Atae. Mogamulizumab, an Anti-CCR4 Monoclonal Antibody, Is a Potent Therapeutic Option for Adult T-cell Leukemia-lymphoma. BioMed Central, 2014.

警告：這些引文格式不一定是100％准確.